Vanda Pharmaceuticals (VNDA) Intangibles (2009 - 2026)
Vanda Pharmaceuticals' Intangibles was $111.13 million in Q3 2026, up 2.1% from $108.84 million a year earlier but down 1.8% from the prior quarter.
Vanda Pharmaceuticals (VNDA) Intangibles (2009 - 2026) Analysis & Trends
At the end of FY2025, Intangibles at Vanda Pharmaceuticals came in at $117.09 million, up 2.6% from FY2024.
- Intangibles shows a five-year compound annual growth rate of 40.3% (FY2020 to FY2025).
- In earlier years, Intangibles was $114.1 million in FY2024 (-6.0%), $121.37 million in FY2023 (+553.8%), $18.57 million in FY2022 (-7.5%) and $20.08 million in FY2021 (-6.9%).
- Quarterly Intangibles has moved between $17.43 million (Q3 2023) and $121.37 million (Q4 2023) over five years.
- Compared with a year earlier, Intangibles has increased for four straight quarters, with an average decline of 1.8% over the last eight quarters.
- The best year-over-year quarter for Intangibles over five years was Q3 2024 (growth of 564.7%); the worst was Q3 2023 (a decline of 8.0%).
- Per Business Quant data, VNDA's Intangibles in the three quarters before Q3 2026 was $113.12 million (Q2 2026), $115.1 million (Q1 2026) and $117.09 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 18.08 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 46.65 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 56.65 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 24.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 11.80 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 38.15 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 19.54 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 13.42 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 45.96 Bn |
| 10 | Vanda Pharmaceuticals | 246.71 Mn | -529.97 Mn | 65.66 Mn | 111.13 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 111.13 Mn |
| Jun 30, 2026 | 113.12 Mn |
| Mar 31, 2026 | 115.10 Mn |
| Dec 31, 2025 | 117.09 Mn |
| Sep 30, 2025 | 108.84 Mn |
| Jun 30, 2025 | 110.59 Mn |
| Mar 31, 2025 | 112.34 Mn |
| Dec 31, 2024 | 114.10 Mn |
| Sep 30, 2024 | 115.85 Mn |
| Jun 30, 2024 | 117.60 Mn |
| Mar 31, 2024 | 119.35 Mn |
| Dec 31, 2023 | 121.37 Mn |
| Sep 30, 2023 | 17.43 Mn |
| Jun 30, 2023 | 17.81 Mn |
| Mar 31, 2023 | 18.19 Mn |
| Dec 31, 2022 | 18.57 Mn |
| Sep 30, 2022 | 18.94 Mn |
| Jun 30, 2022 | 19.32 Mn |
| Mar 31, 2022 | 19.70 Mn |
| Dec 31, 2021 | 20.08 Mn |
Vanda Pharmaceuticals Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=VNDA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "VNDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=VNDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();